Trademark: 77004294
Word
BIOSPHERE
Status
Dead
Status Code
606
Status Date
Monday, October 5, 2009
Serial Number
77004294
Mark Type
4000
Filing Date
Thursday, September 21, 2006
Published for Opposition
Tuesday, January 15, 2008
Abandoned Date
Monday, October 5, 2009

Trademark Owner History
PACIRA PHARMACEUTICALS, INC. - Owner At Publication
SKYEPHARMA INC. - Original Applicant

Classifications
5 PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PARENTERAL CONTROLLED RELEASE OF PROTEINS

Trademark Events
Oct 5, 2009
Abandonment Notice Mailed - No Use Statement Filed
Oct 5, 2009
Abandonment - No Use Statement Filed
Mar 3, 2009
Noa Mailed - Sou Required From Applicant
Jan 21, 2009
Ttab Release Case To Trademarks
Jan 21, 2009
Opposition Terminated No. 999999
Jan 21, 2009
Opposition Dismissed No. 999999
Jul 22, 2008
Opposition Instituted No. 999999
Feb 13, 2008
Extension Of Time To Oppose Received
Jan 17, 2008
Attorney Revoked And/Or Appointed
Jan 17, 2008
Teas Revoke/Appoint Attorney Received
Jan 15, 2008
Published For Opposition
Dec 26, 2007
Notice Of Publication
Dec 11, 2007
Law Office Publication Review Completed
Dec 11, 2007
Assigned To Lie
Nov 4, 2007
Approved For Pub - Principal Register
Oct 9, 2007
Teas/Email Correspondence Entered
Oct 9, 2007
Correspondence Received In Law Office
Oct 9, 2007
Teas Request For Reconsideration Received
Sep 18, 2007
Notification Of Final Refusal Emailed
Sep 18, 2007
Final Refusal E-Mailed
Sep 18, 2007
Final Refusal Written
Aug 11, 2007
Teas/Email Correspondence Entered
Aug 10, 2007
Correspondence Received In Law Office
Aug 10, 2007
Teas Response To Office Action Received
Aug 9, 2007
Attorney Revoked And/Or Appointed
Aug 9, 2007
Teas Revoke/Appoint Attorney Received
Jul 20, 2007
Attorney Revoked And/Or Appointed
Jul 20, 2007
Teas Revoke/Appoint Attorney Received
Jul 11, 2007
Automatic Update Of Assignment Of Ownership
Feb 19, 2007
Non-Final Action E-Mailed
Feb 19, 2007
Non-Final Action Written
Feb 11, 2007
Assigned To Examiner
Sep 27, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24